gpt-dict.com

舊版 AI 分級 · 資料日期 2026-06-09。尚未採用新版自動摘要；未經專家評讀，涵蓋範圍以本頁來源為限。了解新版流程

維生素 B12 Vitamin B12 × 代謝功能異常相關脂肪肝病

結論：主流反證據

在 MASLD/NAFLD 此特定適應症上證據明確「不支持」B12 補充：L2 引用最新系統性回顧與統合分析（361 NAFLD vs 510 對照）顯示血清 B12 與 NAFLD 風險無顯著相關，RCT 顯示 B12 補充雖降低同半胱胺酸但對肝臟脂肪變性無改善，且 2023 年雙向 Mendelian randomization 研究進一步指出基因預測較高 B12 濃度與 NAFLD 風險升高呈正相關（合併 OR 1.

D 🔴 D 反證據 主流反證據 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

在 MASLD/NAFLD 此特定適應症上證據明確「不支持」B12 補充：L2 引用最新系統性回顧與統合分析（361 NAFLD vs 510 對照）顯示血清 B12 與 NAFLD 風險無顯著相關，RCT 顯示 B12 補充雖降低同半胱胺酸但對肝臟脂肪變性無改善，且 2023 年雙向 Mendelian randomization 研究進一步指出基因預測較高 B12 濃度與 NAFLD 風險升高呈正相關（合併 OR 1.30）。

所有 L5 共識來源（Mayo、Cleveland、Harvard、AASLD/EASL）皆無 B12 對 MASLD 的建議，AASLD/EASL 指引完全未列入。

等級給 D（against），因為 MR 證據暗示潛在反向風險，且 RCT 已直接否定療效。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.47
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
D · 主流反證據
信心度
90%
證據方向一致性高
證據層級
E3
單篇高品質統合分析

各層「支持此療效」的程度

分數越低＝該層越不支持
L11 AI 複核獨立判讀
0.30
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.55
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.465
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data
PMID: 36950332 2023 Cohort n = 45,576
結論：Genetically predicted higher vitamin B12 was associated with INCREASED NAFLD risk (combined OR 1.30, 95% CI 1.13-1.48, p<0.001 per SD), with reverse causality also seen (NAFLD liability raised B12, beta 0.08, p=0.034).
效應量：OR 1.30 (95% CI 1.13-1.48) per SD increase in B12
前往 PubMed
The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial
PMID: 35982162 2022 RCT (double-blind) n = 40
結論：B12 significantly lowered the surrogate marker homocysteine vs placebo (median -2.1 vs -0.003 umol/L, p=0.038), but between-group differences in liver steatosis, ALT and fasting glucose were NOT significant.
🟠 品質有限 學術資助 效應量：Homocysteine change -2.1 vs -0.003 umol/L (p=0.038); no significant between-group change in steatosis/ALT
前往 PubMed
Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial
PMID: 39202647 2024 RCT (double-blind) n = 196
結論：The B12-containing cocktail reduced CAP by 4% and TE by 7.8% vs placebo (both p<0.05), but B12 was co-administered with folate, betaine, omega-3 and choline so its independent effect cannot be isolated.
🟠 品質有限 政府資助 效應量：CAP -4% (p<0.05); TE -7.8% (p<0.05) for combined cocktail
前往 PubMed
Associations of serum folate and vitamin B12 levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study
PMID: 39703860 2024 Cohort n = 2,125
結論：Higher serum B12 was associated with LOWER all-cause mortality (Q3 HR 0.58, 95% CI 0.39-0.86, p=0.008; Q4 HR 0.72, 95% CI 0.54-0.96, p=0.026), but this is observational and likely confounded by reverse causation (low B12 marking sicker patients).
效應量：Q3 HR 0.58 (0.39-0.86); Q4 HR 0.72 (0.54-0.96) vs lowest quartile
前往 PubMed
The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004
PMID: 35334881 2022 Cross-sectional n = 8,397
結論：Functional B12-pathway markers were associated with advanced fibrosis (homocysteine OR 2.76, 95% CI 1.49-5.11; methylmalonic acid OR 1.41, 95% CI 1.10-1.80), indicating impaired B12 metabolism tracks with worse disease rather than B12 being protective.
政府資助 效應量：Homocysteine OR 2.76 (1.49-5.11); MMA OR 1.41 (1.10-1.80) for advanced fibrosis
前往 PubMed
The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review
PMID: 34522493 2021 系統性回顧 n = 17
結論：Narrative review of 17 studies concluded vitamin deficiency associates with NAFLD and that B12 shows 'promise', but found no quantitative pooled effect and explicitly stated more well-designed human trials are needed.
🟠 品質有限
前往 PubMed

L4a US FDA
支持
NUTRIENT SUPPLEMENT 來源↗
L4b EU EFSA
支持
a cause and effect relationship has been established 來源↗
L4c UK NHS
支持
Adults aged 19 to 64 need about 1.5 micrograms a day of vitamin B12. 來源↗
L4d TW TFDA / 衛福部
支持
維生素B12之足夠攝取量(AI)成人為每日2.4微克 來源↗
L4e WHO
支持
Vitamin B12 or folate supplementation during pregnancy is not recommended as an intervention to improve maternal and infant health outcomes 來源↗

L5a NIH Office of Dietary Supplements
支持
Vitamin B12 supplementation appears to have no beneficial effect on performance in the absence of a nutritional deficit. 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
中性
— 本適應症無對應資料

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽

台灣社群普遍將 B12 視為「B 群」的一部分，認為對護肝代謝有輔助作用，但很少有人單獨討論 B12 對脂肪肝的療效；多數討論認為改善脂肪肝關鍵在減重、飲食、運動，B 群只是配角。

💬社群實感

意見分歧

破解迷思 社群最常見的 5 個誤解
✓
事實誤以為吃 B 群（含 B12）就能直接消脂肪肝
✓
事實把護肝保健食品（薑黃、牛樟芝、卵磷脂、B 群）一起吃當作可以取代減重
✓
事實認為高劑量 B12 越多越好，忽略過量也可能造成負擔
✓
事實把素食者缺 B12 的問題與脂肪肝混為一談
✓
事實誤以為化學合成 B 群吃久了會有依賴性，天然來源才安全
🩹 社群通報的副作用
  • 尿液變黃 (B 群常見現象)
  • 腸胃不適、噁心
  • 空腹服用導致胃悶
  • 失眠（晚上服用時）
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • 大研生醫
  • BHK's
  • Swanson
  • 三多
  • 如新 Pharmanex LifePak
  • Schiff 旭福

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

DHC 維他命 B 群 60 日份

代表來源 ↗
L10b · TFDA 法定身份 官方認定

成人B12建議攝取量2.4微克

來源 ↗

  • 減重 7-10%
  • 地中海飲食
  • Resmetirom (Rezdiffra)
✓ PMID 可查證引用皆附 NCBI PubMed 原始連結
🔬 6 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-09 claim_version: v10 engine_version: v1.0 claim_id: CLM-COND-masld-INT-vitamin-b12-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-masld-INT-vitamin-b12-001/",
  "datePublished": "2026-06-09",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "維生素 B12能改善代謝功能異常相關脂肪肝病",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 1,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🔴 D 反證據"
  }
}